Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Inhibition of tumorigenicity by the 5'-untranslated RNA of the human c-myc P0 transcript.

Blume SW, Miller DM, Guarcello V, Shrestha K, Meng Z, Snyder RC, Grizzle WE, Ruppert JM, Gartland GL, Stockard CR, Jones DE Jr, Emanuel PD.

Exp Cell Res. 2003 Aug 1;288(1):131-42.

PMID:
12878165
2.

Translation of the human c-myc P0 tricistronic mRNA involves two independent internal ribosome entry sites.

Nanbru C, Prats AC, Droogmans L, Defrance P, Huez G, Kruys V.

Oncogene. 2001 Jul 12;20(31):4270-80.

5.

Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.

Kim J, Roh M, Abdulkadir SA.

BMC Cancer. 2010 Jun 1;10:248. doi: 10.1186/1471-2407-10-248.

6.

Analysis of the c-myc IRES; a potential role for cell-type specific trans-acting factors and the nuclear compartment.

Stoneley M, Subkhankulova T, Le Quesne JP, Coldwell MJ, Jopling CL, Belsham GJ, Willis AE.

Nucleic Acids Res. 2000 Feb 1;28(3):687-94.

7.

Glucocorticoid regulation of c-myc promoter utilization in P1798 T-lymphoma cells.

Ma T, Mahajan PB, Thompson EA.

Mol Endocrinol. 1992 Jun;6(6):960-8.

PMID:
1495494
9.

Evidence that Myc isoforms transcriptionally repress caveolin-1 gene expression via an INR-dependent mechanism.

Park DS, Razani B, Lasorella A, Schreiber-Agus N, Pestell RG, Iavarone A, Lisanti MP.

Biochemistry. 2001 Mar 20;40(11):3354-62.

PMID:
11258956
10.

Characterization of new human c-myc mRNA species produced by alternative splicing.

Bodescot M, Brison O.

Gene. 1996 Sep 26;174(1):115-20.

PMID:
8863737
11.

Two haplotypes of 5' untranslated region in L-myc gene with different internal ribosome entry site activity.

Kumimoto H, Yamane Y, Ishizaki K.

Int J Oncol. 2005 Jan;26(1):287-93.

PMID:
15586251
12.

HER2 signaling enhances 5'UTR-mediated translation of c-Myc mRNA.

Galmozzi E, Casalini P, Iorio MV, Casati B, Olgiati C, Ménard S.

J Cell Physiol. 2004 Jul;200(1):82-8.

PMID:
15137060
13.

mrtl-A translation/localization regulatory protein encoded within the human c-myc locus and distributed throughout the endoplasmic and nucleoplasmic reticular network.

Choi H, Jackson NL, Shaw DR, Emanuel PD, Liu YL, Tousson A, Meng Z, Blume SW.

J Cell Biochem. 2008 Nov 1;105(4):1092-108. doi: 10.1002/jcb.21909.

14.

Antiproliferative protein Tob directly regulates c-myc proto-oncogene expression through cytoplasmic polyadenylation element-binding protein CPEB.

Ogami K, Hosoda N, Funakoshi Y, Hoshino S.

Oncogene. 2014 Jan 2;33(1):55-64. doi: 10.1038/onc.2012.548. Epub 2012 Nov 26.

PMID:
23178487
15.

Regulatory domains within the P0 promoter of human c-myc.

Lang JC, Wilkie NM, Clark AM, Chudleigh A, Talbot S, Whitelaw B, Frame MC.

Oncogene. 1991 Nov;6(11):2067-75.

PMID:
1945411
16.

Identification of sequences in c-myc mRNA that regulate its steady-state levels.

Yeilding NM, Rehman MT, Lee WM.

Mol Cell Biol. 1996 Jul;16(7):3511-22.

17.

Physiological Expression and Accumulation of the Products of Two Upstream Open Reading Frames mrtl and MycHex1 Along With p64 and p67 Myc From the Human c-myc Locus.

Ji MH, Kim SK, Kim CY, Phi JH, Jun HJ, Blume SW, Choi HS.

J Cell Biochem. 2016 Jun;117(6):1407-18. doi: 10.1002/jcb.25431. Epub 2015 Dec 2.

PMID:
26552949
18.

Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.

Leonetti C, D'Agnano I, Lozupone F, Valentini A, Geiser T, Zon G, Calabretta B, Citro G C, Zupi G.

J Natl Cancer Inst. 1996 Apr 3;88(7):419-29.

PMID:
8618233
19.
20.

The 5'-untranslated RNA of the human dhfr minor transcript alters transcription pre-initiation complex assembly at the major (core) promoter.

Blume SW, Meng Z, Shrestha K, Snyder RC, Emanuel PD.

J Cell Biochem. 2003 Jan 1;88(1):165-80.

PMID:
12461786

Supplemental Content

Support Center